Head-to-head · WeighScore
Obu Health vs RxSaludable
The verdict
RxSaludable takes it — 63.2/100 to 59.9/100.
RxSaludable grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSaludable is a Spanish-language GLP-1 weight-loss telehealth service (atencion en espanol) offering compounded semaglutide from $99 the first month ($179/mo after) and tirzepatide from $189 the first…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Obu Health | RxSaludable |
|---|---|---|
| WeighScore | 59.9/100 | 63.2/100 |
| Grade | C | C |
| Scorecard rank | #332 | #259 |
| Semaglutide | $190/mo (starting dose, plus a separate fee, compounded) | $179/mo (compounded) |
| Tirzepatide | $239/mo (starting dose, plus a separate fee, compounded) | $269/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #332 · C
Strengths
- LegitScript-certified with publicly displayed ID (44206977)
- Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
- Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
- Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
- 24-hour US board-certified physician response window
Where it loses points
- Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
- No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
- Medical director not named publicly
- No published consultation fee disclosure — unclear whether physician visit is included in medication price
- All sales final per FAQ ('Federal and State law do not allow medication returns')
Graded #259 · C
Strengths
- Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
- Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
- LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
- Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime
Where it loses points
- Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
- Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
- No legal entity name or explicit state-coverage list published on the site
- Compounded GLP-1s are not FDA-approved (the site discloses this)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.